- Home
- ANIX vs OPRX Comparison
ANIX vs OPRX Comparison
Compare ANIX & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- OPRX
- Stock Information
- Founded
- ANIX 1982
- OPRX 2006
- Country
- ANIX United States
- OPRX United States
- Employees
- ANIX N/A
- OPRX N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- OPRX Business Services
- Sector
- ANIX Health Care
- OPRX Consumer Discretionary
- Exchange
- ANIX Nasdaq
- OPRX Nasdaq
- Market Cap
- ANIX 101.4M
- OPRX 111.2M
- IPO Year
- ANIX 1987
- OPRX N/A
- Fundamental
- Price
- ANIX $3.08
- OPRX $3.83
- Analyst Decision
- ANIX Strong Buy
- OPRX Strong Buy
- Analyst Count
- ANIX 2
- OPRX 5
- Target Price
- ANIX $8.50
- OPRX $8.80
- AVG Volume (30 Days)
- ANIX 128.3K
- OPRX 296.1K
- Earning Date
- ANIX 01-14-2025
- OPRX 11-13-2024
- Dividend Yield
- ANIX N/A
- OPRX N/A
- EPS Growth
- ANIX N/A
- OPRX N/A
- EPS
- ANIX N/A
- OPRX N/A
- Revenue
- ANIX N/A
- OPRX $88,179,506.00
- Revenue This Year
- ANIX N/A
- OPRX $43.61
- Revenue Next Year
- ANIX N/A
- OPRX $12.92
- P/E Ratio
- ANIX N/A
- OPRX N/A
- Revenue Growth
- ANIX N/A
- OPRX 40.40
- 52 Week Low
- ANIX $2.15
- OPRX $3.78
- 52 Week High
- ANIX $5.13
- OPRX $16.65
- Technical
- Relative Strength Index (RSI)
- ANIX 42.34
- OPRX 27.71
- Support Level
- ANIX $3.07
- OPRX $5.69
- Resistance Level
- ANIX $4.20
- OPRX $6.36
- Average True Range (ATR)
- ANIX 0.30
- OPRX 0.52
- MACD
- ANIX -0.06
- OPRX -0.09
- Stochastic Oscillator
- ANIX 2.61
- OPRX 1.47
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.